15012456311
當前位置：深圳遠揚化學技術有限公司>>藥物雜質對照品>>雜質對照品>> 替格瑞洛雜質對照品
替格瑞洛雜質對照品 產品介紹：
規格：10mg/25mg/50mg/100mg等多種規格可選。
用途：實驗研發，藥品申報檢測，不得用于臨床醫學診斷。
隨貨提供：所有雜質對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。
國產進口品牌皆有銷售，產品庫時常會有更新，另外，我司有專業研發團隊，可提供部分雜質定制服務，以zui大可能的滿足您雜質對照品的選購需求。
替格瑞洛雜質對照品 雜質列表：
| Ticagrelor | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 1 | (1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 2 | (1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 3 | (1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 4（Mixture of Diastereomers） | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1) |
| Ticagrelor Impurity 5（Mixture of Diastereomers） | (1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1) |
| Ticagrelor Impurity 6 | 2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate |
| Ticagrelor Impurity 7 | (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 8 | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 9 | 2-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
| Ticagrelor Impurity 10 | 5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
| Ticagrelor Impurity 11 | 2-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol |
| Ticagrelor Impurity 12 | (1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 13 | 5-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol |
| Ticagrelor Impurity 14 | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 15 | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 16 | 2-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
| Ticagrelor Impurity 17 | (1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 18 | (1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 19 | (1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 20 | (1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol |
| Ticagrelor Impurity 21 | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 22 | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 23 | sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate |
| Ticagrelor Impurity 24 | (1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 25 | (1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 26 | 2-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol |
| Ticagrelor Impurity 27 | (1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 28 | 7-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine |
| Ticagrelor Impurity 29 | (1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol |
| Ticagrelor Impurity 30 | 2-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
除自主雜質對照品品牌外，我司優勢代理多個進口雜質品牌:EP，USP，JP，LGC,TRC，TLC，Molcan等，*滿足您對雜質對照品的需求。另代理意大利Chromogenix肝素檢測試劑，英國NIBSC標準試劑，Sigma-Aldrich試劑, 美國ChromaDex中草藥標準品，瑞士CaroteNature類胡蘿卜素標準品，法國Extrasynthese中草藥標準品，WHO世界衛生組織藥物標準品，NIST美國國家標準局標準品，IRRM歐洲標準局標準品等各種標準品，CIL美國劍橋同位素標準品，種類齊全，到貨迅速。
英國NIBSC標準品部分產品列表：
10/175 Reteplase Reference Material
13/322 Polio Anti Sabin type 105 (inactivated) Serum
95/596 Interleukin-57 (Human, rDNA derived)
01/509 Meningococcal serogroup W polysaccharide
13/239 Polio Anti Sabin type 22 (inactivated) Serum
07/300 BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent)
13/249 C-Peptide, Human. 104st International Standard.
95/571 Interleukin-32 (Human, rDNA derived)
95/602 Interleukin-63 (Human, rDNA derived)
10/173 Reteplase Reference Material
10/127 Reteplase Reference Material
01/461 Meningococcal serogroup W polysaccharide
13/294 Polio Anti Sabin type 77 (inactivated) Serum
13/233 C-Peptide, Human. 88st International Standard.
95/572 Interleukin-33 (Human, rDNA derived)
03/104-079 HTLV-64 (antibody) Monitor Sample
13/144 Influenza Antigen B/Massachusetts/02/2022 (Egg derived)
13/180 Influenza Antigen B/Massachusetts/02/2058 (Egg derived)
01/528 Meningococcal serogroup W polysaccharide
13/178 C-Peptide, Human. 33st International Standard.
07/373 BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent)
07/324 BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent)
13/241 C-Peptide, Human. 96st International Standard.
07/290 BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent)
03/104-061 HTLV-46 (antibody) Monitor Sample
07/358 BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)
10/185 Reteplase Reference Material
07/364 BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)
03/104-056 HTLV-41 (antibody) Monitor Sample
13/146 C-Peptide, Human. 1st International Standard.
12/B623-083 QCRFLUAH1N1QC1-Influenza AH1N1 QC81
10/158 Reteplase Reference Material
13/229 C-Peptide, Human. 84st International Standard.
01/428 Meningococcal serogroup W polysaccharide
01/449 Meningococcal serogroup W polysaccharide
13/236 Influenza Antigen B/Massachusetts/02/2114 (Egg derived)
13/233 Influenza Antigen B/Massachusetts/02/2111 (Egg derived)
07/359 BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent)
更多關于 的產品信息，請我司。
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
化工儀器網